Bank of America’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-67,353
| Closed | -$9.43M | – | 7681 |
|
|
2018
Q4 | $9.43M | Buy |
67,353
+20,450
| +44% | +$3.1M | ﹤0.01% | 2369 |
|
|
2018
Q3 | $8.01M | Buy |
46,903
+9,947
| +27% | +$1.67M | ﹤0.01% | 2707 |
|
|
2018
Q2 | $6.41M | Buy |
36,956
+20,329
| +122% | +$3.05M | ﹤0.01% | 2897 |
|
|
2018
Q1 | $1.92M | Buy |
16,627
+3,683
| +28% | +$392K | ﹤0.01% | 3911 |
|
|
2017
Q4 | $1.09M | Sell |
12,944
-825
| -6% | -$68.8K | ﹤0.01% | 4432 |
|
|
2017
Q3 | $1.27M | Buy |
13,769
+8,980
| +188% | +$698K | ﹤0.01% | 4346 |
|
|
2017
Q2 | $383K | Sell |
4,789
-3,387
| -41% | -$188K | ﹤0.01% | 5030 |
|
|
2017
Q1 | $344K | Buy |
8,176
+5,063
| +163% | +$209K | ﹤0.01% | 5078 |
|
|
2016
Q4 | $100K | Buy |
3,113
+271
| +10% | +$6.95K | ﹤0.01% | 5627 |
|
|
2016
Q3 | $74K | Buy |
2,842
+113
| +4% | +$2.96K | ﹤0.01% | 5571 |
|
|
2016
Q2 | $63K | Buy |
2,729
+715
| +36% | +$17.8K | ﹤0.01% | 5738 |
|
|
2016
Q1 | $55K | Buy |
2,014
+130
| +7% | +$2.72K | ﹤0.01% | 5751 |
|
|
2015
Q4 | $53K | Sell |
1,884
-119
| -6% | -$3.19K | ﹤0.01% | 6025 |
|
|
2015
Q3 | $35K | Sell |
2,003
-84
| -4% | -$1.64K | ﹤0.01% | 6111 |
|
|
2015
Q2 | $38K | Sell |
2,087
-3,372
| -62% | -$46.1K | ﹤0.01% | 6071 |
|
|
2015
Q1 | $68K | Buy |
+5,459
| New | +$68K | ﹤0.01% | 5513 |
|
Other funds holding LOXO
Bank of America's LOXO Position: Q1 2019 in Review
Bank of America sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 67,353 shares — an estimated $9.43M sold.
Bank of America first reported a position in LOXO in Q1 2015 and held it in 16 quarters. The position peaked at $9.43M in Q4 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.
- Bank of America reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
- Bank of America sold 67,353 Loxo Oncology, Inc shares in Q1 2019, an estimated $9.43M.
- Bank of America first reported a position in Loxo Oncology, Inc in Q1 2015 and held it in 16 quarters.
- Bank of America's Loxo Oncology, Inc position peaked at $9.43M in Q4 2018.
- 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.
Based on Bank of America's 13F filing for Q1 2019, filed 15 May 2019.